14TH INTERNATIONAL ATHENS / SPRINGFIELD SYMPOSIUM ON ADVANCES IN ALZHEIMER THERAPY
Athens HiltonATHENS, GREECE Visit the Venue to read more
Leading scientists will discuss new targets and drugs for the treatment of Alzheimer’s disease and novel approaches to current therapy. An oral communication session will be open to young scientists.
We expect approximately 1000 participants, mostly neurologists, psychiatrists, geriatricians and pharmacologists.
Drug Discovery and Treatment Development
New Preclinical Models of Alzheimer’s Disease
Clinical Trials on Alzheimer’s Disease: New Designs and Measures
Early Diagnosis of Alzheimer’s Disease
Advances in Brain Imaging and Biomarkers
Emerging Novel Therapeutic Targets
Preventive Trials of Alzheimer’s Disease
What is New in Immunization?
Tau Pathology and Tau-Focused Therapy: What’s New?
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Links for submitting abstracts will be on the website in early September.
For invited speakers:
Speakers’ abstracts will be published as an electronic supplement to Neurobiology of Aging.
Speakers’ abstract submission deadline is: November 1, 2015.
For oral communications and posters:
Participants are invited to submit abstracts for oral communications and poster presentations. Abstract submission deadline for oral communications and posters is: November 1, 2015.
Abstracts selected for oral communications and poster presentations during the symposium will be listed in the final program and published on the symposium website after the conference.
Southern Illinois University School of Medicine, Springﬁeld, Illinois, USA
University of Geneva Medical School, Geneva, Switzerland
Geneva University Hospitals, Department of Internal Medicine, Rehabilitation and Geriatrics, Geneva, Switzerland
Ann Hamilton , Coordinator USA , Southern Illinois University School of Medicine